1,190
Participants
Start Date
January 28, 2025
Primary Completion Date
December 30, 2027
Study Completion Date
December 30, 2027
Pentavalent vaccine
Whole-cell pertussis pentavalent vaccine (wP-Penta): Each 0.5 ml dose contains diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen, Haemophilus influenzae type b conjugate
Hexavalent vaccine
Whole-cell pertussis hexavalent vaccine (wP-Hexa): Each 0.5 ml dose contains diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen, Haemophilus influenzae type b conjugate, and inactivated polioviruses to all three poliovirus types: type 1 , 2 and 3
Inactivated poliovirus vaccine (IPV)
one dose of IPV (0.5 mL) contains inactivated polioviruses to all three poliovirus types: type 1, 2 and 3
Bivalent oral polio vaccine (bOPV)
Contain two poliovirus types: type 1 and 3
Fractional IPV( fIPV)
The dose of fIPV is 0.1 mL or 1/5th of a full dose
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER